Reactive antitachycardia pacing of CRT devices eases atrial fibrillation burden
27 Apr 2020
byTristan Manalac
Reactive antitachycardia pacing (ATP), a new-generation ATP, safely reduces the burden of atrial fibrillation (AF) in patients with cardiac resynchronization therapy (CRT) device implants, according to a recent study.